{"label_logits": [5.022961139678955, 3.727428436279297, -12.778963088989258], "label_probs": [0.7850821614265442, 0.21491780877113342, 1.4575983087183886e-08], "claim": "A subtype of anti-nuclear antibodies is found in 50 % -70 % of patients with systemic lupus erythematosus.", "premise_source_doc_id": "Anti-histone_antibodies", "premise_source_doc_line_num": 0, "premise_source_doc_sentence": "Anti-histone antibodies are autoantibodies that are found in 50 % -70 % of patients with systemic lupus erythematosus  (  SLE  )  and in more than 95 % of patients with drug-induced lupus erythematosus ."}
{"label_logits": [4.705785274505615, 4.159775257110596, -12.657492637634277], "label_probs": [0.6332094073295593, 0.36679062247276306, 1.8229375342571075e-08], "claim": "A subtype of anti-nuclear antibodies is found in 50 % -70 % of patients with systemic lupus erythematosus.", "premise_source_doc_id": "RA33", "premise_source_doc_line_num": 8, "premise_source_doc_sentence": "Anti-RA33 occur in approximately 15-35 % of patients with RA , in 20-25 % of patients with systemic lupus erythematosus and in 35-40 % of patients with mixed connective tissue disease , being rare or absent in other forms of arthritis ."}
